Log in Subscribe Front Page Current Issue Real Briefs Recent Trades Subscribe/Renew Events Advertise Contact Us
Mon, Dec 4
A Compendium of Property & Capital News
Dec 4

Following 74M Assembly Square Top-Off, Greystar Hires DeNoble To Lead Life Science Group

May 23, 2023
74 Middlesex Avenue, Somerville MA

BOSTON — Greystar Real Estate Partners, LLC (“Greystar”), recently announced that Matt DeNoble has joined the company as Senior Director, Life Science Investment Management to expand its burgeoning national life sciences strategy.

Greystar’s Life Sciences platform initially prioritizes the Boston market and plans to expand to other top-tier life science clusters in areas where they have existing, local development teams. In 2022, Greystar formalized its entry into the life sciences sector with the start of vertical construction of 74 Middlesex Avenue (“74M”) in the Assembly Square district of Somerville, Massachusetts. The 465,000-square-foot, 15-story purpose-built lab and office building will contribute to the district’s emerging life sciences cluster and is set to deliver in Spring 2024.

“Greystar is delighted to welcome Matt as we bolster our life sciences team to pursue new development opportunities,” said Gary Kerr, Managing Director of Development and leader of Life Sciences strategy for Greystar. “We are especially excited about Matt’s significant experience in numerous markets and with this particular asset class. His deep expertise will be incredibly valuable in expanding our development presence within the region and beyond.”

In his new role, DeNoble will be charged with overseeing the development of a market-leading asset management platform that emphasizes tenant success, while expanding tenant relationships in Greater Boston and nationally. He will also support the underwriting of new acquisitions, the lease-up of new development opportunities, and the supervision of third-party brokerage and management relationships. DeNoble will build out a team to support these efforts on a national level.

DeNoble is a seasoned veteran in asset management. Over the last two decades, he has overseen more than 100 executed leases and renewals totaling more than 2 million square feet, as well as dispositions and recapitalizations in excess of 3 million square feet and $1.3 billion. DeNoble most recently served as Director of Asset Management at The Bulfinch Companies, overseeing a substantial portfolio of property types totaling 4.4 million square feet in Greater Boston.

“I’m excited to continue to elevate Greystar as a national leader in the life sciences space and identify large-scale core opportunities in areas propelled by the innovation economy,” said Matt DeNoble. “Greystar has a sterling reputation in deal making and tenant experience, and I look forward to expanding our portfolio.”

Matt DeNoble